Clinical Trial Update: PSMA PET Imaging of Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 clinical trial evaluating PSMA PET imaging in recurrent prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Adenocarcinoma, Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING